CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2003-09-02): Zero mortality seen among living liver donors in Japan

Clinical

Zero mortality seen among living liver donors in Japan

Last Updated: 2003-09-02 13:57:36 -0400 (Reuters Health)

NEW YORK (Reuters Health) - In contrast with results in Western countries, no perioperative mortality has occurred among living liver donors in Japan, according to a report published in the August 30th of The Lancet.

Although Japan is one of the leading countries for living donor liver transplantation (LDLT), no national surveys have been conducted to assess the morbidity and mortality of such donors.

To investigate, Dr. Morito Monden, from Osaka University, and colleagues assessed the outcomes of 1841 patients who donated a portion of their liver since the LDLT program began in Japan in November 13, 1989.

None of the patients died around the time of surgery, the authors note. However, 12% of donors did experience postoperative complications.

Donation of the right liver lobe rather than the lateral segment or left lobe graft was tied to a significantly higher risk of complications (p < 0.0001 for both). In line with this finding, right liver lobe donors were hospitalized about 4 days longer, on average, than donors of other segments.

Twenty-three donors required reoperation and the most common reason was for biliary complications. The liver segment donated did not significantly influence the risk of reoperation.

In a related editorial, Dr. Owen S. Surman and Dr. Martin Hertl, from Massachusetts General Hospital in Boston, note that more must be done to ensure the safety of living liver donors.

"In the end we must rely on other avenues for treatment of organ failure, but until such time, careful selection of the donor and keeping in mind that donor safety over-rides benefit for the recipient has to be the 'credo' of the transplant team," the editorialists add.

Lancet 2003;362:674,687-690.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.